DCF — LOGAN HEALTH CONRAD
Enterprise Value: $-46.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-46.3M
Enterprise Value
$-14.2M
PV of Cash Flows
$-32.1M
PV of Terminal Value
$-51.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $16.4M | $-3.1M | -19.0% | $-3.8M | $-3.5M |
| Year 2 | $16.9M | $-3.0M | -18.0% | $-3.8M | $-3.1M |
| Year 3 | $17.4M | $-3.0M | -17.0% | $-3.7M | $-2.8M |
| Year 4 | $18.0M | $-3.0M | -16.0% | $-3.7M | $-2.5M |
| Year 5 | $18.5M | $-3.0M | -16.0% | $-3.8M | $-2.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-46.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$16.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.19477510513987276
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5